Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Hot Flashes 2Breast Neoplasms 2

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 282Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Completed × Magnesium Oxide × Clear all
NCT01439945 2017-04-04

Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Completed
289 enrolled 13 charts
Breast

Breast Neoplasms, Hot Flashes

NCT01008904 2016-06-21

Magnesium Oxide in Treating Hot Flashes in Menopausal Women With Cancer

Virginia Commonwealth University

Phase 2 Completed
31 enrolled 8 charts
Breast

Breast Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡